| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.0084 | 0.8 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.8 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.008 | 0.8 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0072 | 0.8 |